Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity

R Sharma, B Reinstadler, K Engelstad… - The Journal of …, 2021 - Am Soc Clin Investig
Mitochondrial disorders represent a large collection of rare syndromes that are difficult to
manage both because we do not fully understand biochemical pathogenesis and because …

Blood biomarkers of mitochondrial disease—One for all or all for one?

A Suomalainen - Handbook of Clinical Neurology, 2023 - Elsevier
The mitochondrial disease group consists of different disorders with unprecedented
variability of clinical manifestations and tissue-specific symptoms. Their tissue-specific stress …

Systems biology approaches toward understanding primary mitochondrial diseases

EM Maldonado, F Taha, J Rahman, S Rahman - Frontiers in genetics, 2019 - frontiersin.org
Primary mitochondrial diseases form one of the most common and severe groups of genetic
disease, with a birth prevalence of at least 1 in 5000. These disorders are multi-genic and …

Central systolic pressure and a nonessential amino acid metabolomics profile: the African Prospective study on the Early Detection and Identification of …

CM Mels, C Delles, R Louw, AE Schutte - Journal of Hypertension, 2019 - journals.lww.com
Objectives: Early-life exposures to cardiovascular risk factors may manifest as early vascular
ageing, a phenomenon to which black populations are more prone. The metabolome …

Optimising a urinary extraction method for non-targeted GC–MS metabolomics

C Olivier, B Allen, L Luies - Scientific Reports, 2023 - nature.com
Urine is ideal for non-targeted metabolomics, providing valuable insights into normal and
pathological cellular processes. Optimal extraction is critical since non-targeted …

Mitochondrial oxidative phosphorylation is impaired in TALLYHO mice, a new obesity and type 2 diabetes animal model

CA Hunter, F Kartal, ZC Koc, T Murphy, JH Kim… - The international journal …, 2019 - Elsevier
Type 2 diabetes has become an epidemic disease largely explained by the dramatic
increase in obesity in recent years. Mitochondrial dysfunction is suggested as an underlying …

One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m. 3243A> G mutation

K Esterhuizen, JZ Lindeque, S Mason… - Metabolomics, 2021 - Springer
Abstract Introduction The m. 3243A> G mitochondrial DNA mutation is one of the most
common mitochondrial disease-causing mutations, with a carrier rate as high as 1: 400. This …

[HTML][HTML] CRISPR-Cas9 mediated knockout of NDUFS4 in human iPSCs: A model for mitochondrial complex I deficiency

S Goolab, K Terburgh, C du Plessis… - … et Biophysica Acta (BBA …, 2025 - Elsevier
Mitochondrial diseases, often caused by defects in complex I (CI) of the oxidative
phosphorylation system, currently lack curative treatments. Human-relevant, high-throughput …

[HTML][HTML] Aberrant BCAA and glutamate metabolism linked to regional neurodegeneration in a mouse model of Leigh syndrome

K Terburgh, J Coetzer, JZ Lindeque… - … et Biophysica Acta (BBA …, 2021 - Elsevier
The dysfunction of respiratory chain complex I (CI) is the most common form of mitochondrial
disease that most often presents as Leigh syndrome (LS) in children—a severe …

[HTML][HTML] Metrics of progression and prognosis in untreated adults with thymidine kinase 2 deficiency: An observational study

C Domínguez-González, A Hernández-Voth… - Neuromuscular …, 2022 - Elsevier
This historical cohort study evaluated clinical characteristics of progression and prognosis in
adults with thymidine kinase 2 deficiency (TK2d). Records were available for 17 untreated …